MedPath

tilization Rates / Implementation Rates of the Hepatitis B and C screening within the Check-Up35+ in the German primary care setting after initiatives by the Federal Joint Committee (G-BA)

Conditions
B18.2
B18.11
Chronic viral hepatitis C
Registration Number
DRKS00029166
Lead Sponsor
niversitätsklinikum LeipzigKlinik für Gastroenterologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
286192
Inclusion Criteria

All Check-up 35+” patients will be included in the analysis in the database from 01 Oct 2021 – 30 Sep 2022.

Hepatitis B (HBsAg) and C (anti-HCV) screenings within the Check-Up 35+” are identified by the code GOP 01865. The codes GOP 01866 and 01867 are used for the analysis of HBV-DNA and HCV-RNA (PCR) in case of positive HBsAg and anti-HCV screening results, respectively.

Exclusion Criteria

No specific exclusion criteria

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of HBsAg and anti-HCV screenings ordered within the study period compared to the total number of Check-Up lab requests.
Secondary Outcome Measures
NameTimeMethod
- Proportion of positive HBV-DNA and HCV-RNA results<br>- Above results stratified according to age, sex, and geographical region<br>- Proportion of unjustified screening requests (i.e. double-requests).<br>- These proportions will be compared between the time periods before the COVID-19 pandemic and after the G-BA took effect.
© Copyright 2025. All Rights Reserved by MedPath